首页> 外文OA文献 >PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

【2h】

PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

机译：基于随机对照试验的荟萃分析，PCV6评估20毫克以上20毫克以上罗伐他汀的最终疗效的增加，基于随机对照试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kingslake SL; Edwards SJ;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of sequential rosuvastatin doses in hypercholesterolaemia: A meta-analysis of randomised controlled trials [J] . GrayJ., EdwardsS.J., LipG.Y.H. Current medical research and opinion . 2010,第3期

机译：瑞舒伐他汀顺序剂量高胆固醇血症的比较：一项随机对照试验的荟萃分析
2. The Effect of Patient Characteristics on Acupuncture Treatment Outcomes An Individual Patient Data Meta-Analysis of 20,827 Chronic Pain Patients in Randomized Controlled Trials [J] . Witt Claudia M., Vertosick Emily A., Foster Nadine E., The clinical journal of pain . 2019,第5期

机译：患者特征对针灸治疗的影响结果是随机对照试验中20,827例慢性疼痛患者的个体患者数据荟萃分析
3. Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators [J] . Beth Stuart, Christopher C Butler, Daniel Farewell, BMJ Open . 2015,第3期

机译：经阿莫西林治疗LRTI的依从性调整后的利弊估算：使用基于随机性的功效估算器对12个国家的随机安慰剂对照试验进行二次分析
4. A Health Belief Messaging Framework and a Randomized Controlled Trial of an SMS-Based Intervention for Cancer Patient Outcomes [C] . Coursaris Constantinos K., Spoelstra Sandra L., Given Charles W., Annual Hawaii International Conference on System Sciences . 2015

机译：健康信念消息传递框架和基于SMS的癌症患者预后干预的随机对照试验。
5. Exercise adherence and contamination in a randomized control trial of a home-based walking program among patients receiving active cancer treatment. [D] . Shang, Jingjing. 2009

机译：在接受主动癌症治疗的患者中，一项基于家庭步行计划的随机对照试验中的运动依从性和污染情况。
6. Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: secondary analysis of a 12-country randomised placebo-controlled trial using randomisation-based efficacy estimators [O] . David Gillespie, Kerenza Hood, Daniel Farewell, 2015

机译：经阿莫西林治疗LRTI的依从性调整后的利弊估算：使用基于随机的功效估算器对12个国家的随机安慰剂对照试验进行二次分析
7. PCV22 TOLERABILITY OF ROSUVASTATIN 40 MG COMPARED TO 20 MG IN THE TREATMENT OF HYPERCHOLESTEROLAEMIA: EVIDENCE FROM RANDOMISED CONTROLLED TRIALS [O] . Edwards SJ, Kingslake SL 2008

机译：罗格伐他汀40毫克与20毫克罗伐他汀在高胆固醇血症治疗中的PCV22耐受性：来自随机对照试验的证据

PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

著录项

引文网络

相似文献

相关主题

期刊订阅